Arterial Thrombosis Market, By Treatment Type, By Condition, By Distribution Channel, By Diagnosis, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Arterial Thrombosis Market size was valued at US$ 5,045.84 Million in 2025, expanding at a CAGR of 10.16% from 2026 to 2033.

Arterial thrombosis is a medical condition in which a blood clot develops inside an artery and restricts the normal flow of oxygen-rich blood to important organs or body tissues. It is commonly associated with heart attacks, ischemic strokes, and circulation-related complications. The condition usually occurs when fatty deposits or damage within artery walls trigger clot formation. Factors such as smoking, diabetes, obesity, high blood pressure, and aging may increase the possibility of arterial blockage. Early diagnosis and timely medical care are important as untreated clots can interrupt blood supply and create severe health complications affecting the heart, brain, or limbs.

This ailment is gaining wider healthcare attention as cardiovascular and stroke-related disorders continue to increase globally. According to the World Health Organization (WHO), cardiovascular diseases cause around 17.9 million deaths annually worldwide, highlighting the need for improved clot management and vascular care services. The Centers for Disease Control and Prevention also reported that nearly 805,000 people experience heart attacks each year in the United States, increasing demand for thrombosis management and vascular intervention services. Meanwhile, firms like, Boston Scientific continue expanding thrombectomy and interventional cardiology technologies to support hospitals managing arterial clot-related emergencies worldwide.

Arterial Thrombosis Market- Market Dynamics

Growth in early diagnosis and preventive healthcare programs

Advances in early diagnosis and preventive healthcare programs are becoming an important aspect supporting the Arterial Thrombosis market, as it allows healthcare systems to recognize blood clot risks at an earlier stage and decrease severe problems like stroke and heart attack. When conditions are detected early through routine screening and improved awareness, patients can receive timely anticoagulant therapy or minimally invasive intervention, which helps lower emergency cases and long-term treatment burden. According to the Indian Council of Medical Research (ICMR), national screening initiatives for hypertension and cardiovascular risks are expanding across public health centers, improving early identification of vascular disorders. The UK National Health Service (NHS) continues to reinforce preventive cardiac check-up plans for high-risk inhabitants.

The European Society of Cardiology (ESC) also promotes structured screening guidelines for early detection of arterial disease. From an industry point of view, Siemens Healthineers is enhancing advanced imaging systems that help in detecting arterial blockages at an early stage, supporting preventive care strategies. Additionally, GE HealthCare is focusing on diagnostic imaging technologies that enable faster identification of vascular abnormalities in hospitals.

Arterial Thrombosis Market- Segmentation Analysis:

The Global Arterial Thrombosis Market is segmented on the basis of Treatment Type, Condition, Distribution Channel, Diagnosis, End User, and Region.

As per condition categories, cerebral arterial thrombosis demonstrates a notable contribution in the arterial thrombosis illness-based structure as it signifies a major part of emergency neurological cases and needs instant medical intervention to avoid long-term disability. Its importance is increasing due to rising stroke-related hospital admissions and growing demand for rapid clot removal therapies and imaging diagnostics. Many contributors, Abbott Laboratories has expanded its neurovascular devices used in stroke and clot removal procedures, supporting better clinical outcomes in ischemic conditions. Also, Medtronic continues to advance mechanical thrombectomy systems designed specifically for cerebral clot retrieval, improving treatment speed and recovery outcomes in stroke care settings.

By type of distribution channel, market is divided into three kinds: online pharmacies, hospital pharmacies, and retail pharmacies. The retail pharmacies display a notable participation in the market, as many treatments comprise long-term oral anticoagulants and preventive medicines that patients want to refill regularly. This channel provides continuous access, better medication adherence, and easy availability outside hospitals, making it important for chronic management of arterial clot-related conditions. Among industry participants, Bayer AG supports widespread retail availability of anticoagulant medicines used in thrombosis management across global pharmacy networks. In addition, Pfizer also works with retail and community pharmacy systems to improve access to cardiovascular and antithrombotic therapies for long-term patient care.

Arterial Thrombosis Market- Geographical Insights

From a regional healthcare viewpoint, rising elderly populations and increasing prevalence of cardiovascular conditions are supporting demand for arterial thrombosis treatment solutions. North America shows a notable contribution in this field because of its advanced hospital infrastructure, widespread cardiovascular screening programs, strong emergency stroke management systems, and growing use of minimally invasive vascular procedures. According to the Centers for Disease Control and Prevention (CDC), cardiovascular disease caused more than 919,000 deaths in the United States during 2023, while coronary heart disease alone accounted for over 371,000 deaths. (CDC) The National Institutes of Health (NIH) also reported that stroke continues to affect an American nearly every 40 seconds, increasing demand for rapid thrombosis intervention and clot-management therapies.

In the same way, CDC data emphasized that about 805,000 heart attacks occur yearly in the country, signifying a substantial problem of arterial blockage disorders. Meanwhile, Boston Scientific continues to increase its thrombectomy and interventional cardiology technologies to support hospitals treating arterial clot conditions. These clinical research activities and public awareness initiatives are helping maintain steady healthcare advancement across the region.

Japan Arterial Thrombosis Market- Country Insights

Japan is witnessing growing attention to arterial thrombosis management due to its fast-aging population, strong universal healthcare structure, and increasing burden of cardiovascular and cerebrovascular disorders. According to research associated with Japan's national health datasets, average life expectancy reached 81.4 years for men and 87.5 years for women, contributing to increased demand for long-term vascular and thrombosis-related care services. Studies linked with the Japanese healthcare system also highlighted that circulatory diseases remain highly prevalent among citizens aged 75 years and above, reflecting continued pressure on cardiac and stroke treatment infrastructure. Furthermore, national patient survey findings released through Japan's pharmaceutical industry research body showed that cerebrovascular disease patients continued to require substantial hospital and outpatient support across the country. Meanwhile, Terumo Corporation is expanding vascular intervention technologies and thrombectomy-related solutions to support minimally invasive clot treatment procedures in Japanese hospitals.

Arterial Thrombosis Market- Competitive Landscape:

Due to the rise in cardiovascular illnesses, stroke cases, and arterial blockage-related emergencies, the arterial thrombosis sector is observing stable participation from global pharmaceutical corporations, medical device manufacturers, and vascular therapy developers. Businesses are focusing on expanding treatment accessibility through hospital partnerships, digital healthcare support, catheter-based technologies, and advanced anticoagulant therapies. Products and services are distributed through hospital procurement systems, specialty clinics, direct sales teams, healthcare distributors, and online medical supply platforms.

Major contributors, including Johnson & Johnson, Bristol Myers Squibb, Bayer AG, Abbott Laboratories, and Boston Scientific, are firming their existence through innovation in clot management and minimally invasive vascular procedures. For instance, Boston Scientific announced advancements in its thrombectomy and interventional cardiology portfolio to support faster arterial clot removal procedures. Similarly, Bayer AG expanded research collaborations linked with anticoagulant therapies for cardiovascular and thrombotic conditions.

Recent Developments:

In October 2025, Remedy Robotics announced a strategic partnership with Mission Thrombectomy to expand access to robotic-assisted thrombectomy procedures for stroke patients. The partnership aimed to improve accessibility of advanced clot-removal treatment technologies across healthcare systems.

In July 2025, Stryker introduced the next-generation InThrill(R) Thrombectomy System for arteriovenous access and small vessel thrombus treatment. The upgraded platform was developed to improve clot extraction efficiency and streamline thrombectomy procedures in vascular care settings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTERIAL THROMBOSIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Medtronic
Boston Scientific Corporation
Abbott Laboratories
Johnson & Johnson (Cerenovus)
Stryker Corporation
Penumbra Inc.
Terumo Corporation
Becton, Dickinson and Company (BD)
Edwards Lifesciences
AngioDynamics Inc.
Cook Medical
Cardinal Health
Merit Medical Systems
Philips Healthcare
Remedy Robotics
Siemens Healthineers
MicroPort Scientific Corporation
Kaneka Corporation
Acandis GmbH
Others

GLOBAL ARTERIAL THROMBOSIS MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2020 - 2033

Anticoagulants
Direct Oral Anticoagulants (DOACs)
Vitamin K Antagonists
Heparin & Low Molecular Weight Heparin
Combination Therapies
Antiplatelet Drugs
Thrombolytics / Fibrinolytics
Others

GLOBAL ARTERIAL THROMBOSIS MARKET, BY CONDITION- MARKET ANALYSIS, 2020 - 2033

Peripheral Arterial Thrombosis
Coronary Artery Thrombosis
Renal / Mesenteric Arterial Thrombosis
Cerebral Arterial Thrombosis (Ischemic Stroke)
Others

GLOBAL ARTERIAL THROMBOSIS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033

Online Pharmacies
Hospital Pharmacies
Retail Pharmacies
Others

GLOBAL ARTERIAL THROMBOSIS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2020 - 2033

Ultrasound
Diagnostic Imaging (CT, MRI, Angiography)
Electrocardiogram (ECG)
Blood Tests/ Coagulation Profiles
Others

GLOBAL ARTERIAL THROMBOSIS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

Hospitals
Specialty Clinics
Cardiology Centers
Ambulatory Surgical Centers
Others

GLOBAL ARTERIAL THROMBOSIS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6520

1. Arterial Thrombosis Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Arterial Thrombosis Market Snippet by Treatment Type
- 2.1.2. Arterial Thrombosis Market Snippet by Condition
- 2.1.3. Arterial Thrombosis Market Snippet by Distribution Channel
- 2.1.4. Arterial Thrombosis Market Snippet by Diagnosis
- 2.1.5. Arterial Thrombosis Market Snippet by End User
- 2.1.6. Arterial Thrombosis Market Snippet by Country
- 2.1.7. Arterial Thrombosis Market Snippet by Region
2.2. Competitive Insights

3. Arterial Thrombosis Key Market Trends

3.1. Arterial Thrombosis Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Arterial Thrombosis Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Arterial Thrombosis Market Opportunities
3.4. Arterial Thrombosis Market Future Trends

4. Arterial Thrombosis Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Arterial Thrombosis Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Arterial Thrombosis Market Landscape

6.1. Arterial Thrombosis Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Arterial Thrombosis Market - By Treatment Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Treatment Type, 2025 & 2033 (%)
- 7.1.2. Anticoagulants
  - 7.1.2.1. DOACs
  - 7.1.2.2. Vitamin K Antagonists
  - 7.1.2.3. Heparin & Low Molecular Weight Heparin
- 7.1.3. Combination Therapies
- 7.1.4. Antiplatelet Drugs
- 7.1.5. Thrombolytics / Fibrinolytics
- 7.1.6. Others

8. Arterial Thrombosis Market - By Condition

8.1. Overview
- 8.1.1. Segment Share Analysis, By Condition, 2025 & 2033 (%)
- 8.1.2. Peripheral Arterial Thrombosis
- 8.1.3. Coronary Artery Thrombosis
- 8.1.4. Renal / Mesenteric Arterial Thrombosis
- 8.1.5. Cerebral Arterial Thrombosis (Ischemic Stroke)
- 8.1.6. Others

9. Arterial Thrombosis Market - By Distribution Channel

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
- 9.1.2. Online Pharmacies
- 9.1.3. Hospital Pharmacies
- 9.1.4. Retail Pharmacies
- 9.1.5. Others

10. Arterial Thrombosis Market - By Diagnosis

10.1. Overview
- 10.1.1. Segment Share Analysis, By Diagnosis, 2025 & 2033 (%)
- 10.1.2. Ultrasound
- 10.1.3. CT, MRI, Angiography
- 10.1.4. ECG
- 10.1.5. Blood Tests/ Coagulation Profiles
- 10.1.6. Others

11. Arterial Thrombosis Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 11.1.2. Hospitals
- 11.1.3. Specialty Clinics
- 11.1.4. Cardiology Centers
- 11.1.5. Ambulatory Surgical Centers
- 11.1.6. Others

12. Arterial Thrombosis Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Arterial Thrombosis Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Arterial Thrombosis Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.18. Denmark
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Denmark Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Denmark Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Denmark Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.19. Rest of Europe
  - 12.3.19.1. Overview
  - 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.19.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.3.19.4. Rest of the Europe Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.3.19.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.3.19.6. Rest of the Europe Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Arterial Thrombosis Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.17. Taiwan
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Taiwan Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Taiwan Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Taiwan Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.18. Vietnam
  - 12.4.18.1. Overview
  - 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.18.3. Vietnam Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.18.4. Vietnam Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.18.5. Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.18.6. Vietnam Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.19. Rest of APAC
  - 12.4.19.1. Overview
  - 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.19.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.4.19.4. Rest of APAC Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.4.19.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.4.19.6. Rest of APAC Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Arterial Thrombosis Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Arterial Thrombosis Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.15. Iran
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Iran Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Iran Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Iran Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Iran Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.16. Qatar
  - 12.6.16.1. Overview
  - 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.16.3. Qatar Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.6.16.4. Qatar Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.6.16.5. Qatar Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.16.6. Qatar Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.17. Rest of MEA
  - 12.6.17.1. Overview
  - 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.17.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
  - 12.6.17.4. Rest of MEA Market Size and Forecast, By Condition, 2020 - 2033 (US$ Million)
  - 12.6.17.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  - 12.6.17.6. Rest of MEA Market Size and Forecast, By Diagnosis, 2020 - 2033 (US$ Million)
  - 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Arterial Thrombosis Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Medtronic
- 13.2.2. Boston Scientific Corporation
- 13.2.3. Abbott Laboratories
- 13.2.4. Johnson & Johnson (Cerenovus)
- 13.2.5. Stryker Corporation
- 13.2.6. Penumbra Inc.
- 13.2.7. Terumo Corporation
- 13.2.8. Becton, Dickinson and Company (BD)
- 13.2.9. Edwards Lifesciences
- 13.2.10. AngioDynamics Inc.
- 13.2.11. Cook Medical
- 13.2.12. Cardinal Health
- 13.2.13. Merit Medical Systems
- 13.2.14. Philips Healthcare
- 13.2.15. Remedy Robotics
- 13.2.16. Siemens Healthineers
- 13.2.17. MicroPort Scientific Corporation
- 13.2.18. Kaneka Corporation
- 13.2.19. Acandis GmbH
- 13.2.20. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us